home / stock / onct / onct short
Short Information | Oncternal Therapeutics Inc. (NYSE:ONCT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 12,516 |
Total Actual Volume | 269,721 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 626 |
Average Short Percentage | 6.05% |
Is there a ONCT Short Squeeze or Breakout about to happen?
See the ONCT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-11-2020 | $3.897 | $3.90 | $3.98 | $3.86 | 24,284 | 1,000 | 4.12% |
02-03-2020 | $3.819 | $3.75 | $3.89 | $3.72 | 23,478 | 782 | 3.33% |
01-31-2020 | $3.7694 | $3.801 | $3.918 | $3.73 | 9,234 | 46 | 0.5% |
01-30-2020 | $3.921 | $3.72 | $3.921 | $3.711 | 32,511 | 1,000 | 3.08% |
01-29-2020 | $3.8536 | $3.90 | $3.90 | $3.81 | 5,407 | 184 | 3.4% |
01-28-2020 | $3.88 | $3.9433 | $3.9433 | $3.85 | 15,368 | 1,225 | 7.97% |
01-27-2020 | $3.95 | $3.90 | $4.10 | $3.90 | 18,135 | 100 | 0.55% |
01-24-2020 | $4.00 | $3.96 | $4.1578 | $3.95 | 32,271 | 40 | 0.12% |
01-22-2020 | $4.01 | $4.12 | $4.12 | $4.01 | 10,615 | 71 | 0.67% |
01-21-2020 | $4.16 | $4.18 | $4.18 | $3.98 | 18,617 | 827 | 4.44% |
01-17-2020 | $4.12 | $4.20 | $4.20 | $4.12 | 1,697 | 221 | 13.02% |
01-16-2020 | $4.12 | $4.26 | $4.32 | $4.09 | 9,744 | 1,150 | 11.8% |
01-15-2020 | $4.2284 | $4.27 | $4.27 | $4.221 | 1,635 | 25 | 1.53% |
01-14-2020 | $4.02 | $4.15 | $4.32 | $3.95 | 29,218 | 2,560 | 8.76% |
01-13-2020 | $4.34 | $4.05 | $4.34 | $4.05 | 7,565 | 100 | 1.32% |
01-10-2020 | $4.2341 | $4.22 | $4.2607 | $4.10 | 10,623 | 60 | 0.56% |
01-09-2020 | $4.1478 | $4.26 | $4.29 | $4.1478 | 2,757 | 199 | 7.22% |
01-08-2020 | $4.1322 | $4.16 | $4.30 | $4.1313 | 4,982 | 262 | 5.26% |
01-07-2020 | $4.22 | $4.125 | $4.25 | $4.0637 | 3,645 | 664 | 18.22% |
01-06-2020 | $4.29 | $4.22 | $4.3475 | $4.18 | 7,935 | 2,000 | 25.2% |
News, Short Squeeze, Breakout and More Instantly...
Oncternal Therapeutics Inc. Company Name:
ONCT Stock Symbol:
NYSE Market:
Oncternal Therapeutics Inc. Website:
2024-06-26 15:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that enrollment has been completed and dosing initiated for the fifth dose cohort of its Phas...
Fourth dosing cohort at 300 mg per day is fully enrolled for the Phase 1/2 study with ONCT-534, our dual-action androgen receptor inhibitor (DAARI), for patients with advanced prostate cancer who are resistant to approved androgen receptor pathway inhibitors; initial data readout expected in the ...